Business Context and Reporting Period
Company: AE Biofuels, Inc. (formerly AEMETIS, INC)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2009
Business Overview: AE Biofuels is an international biofuels company focused on developing, acquiring, and operating next-generation fuel-grade ethanol and biodiesel facilities. Key operations include a biodiesel manufacturing facility in Kakinada, India (operational since November 2008) and a cellulosic ethanol commercial demonstration facility in Butte, Montana (operational since August 2008). The Company is currently in a development stage with minimal revenues and significant accumulated deficits.
Key Financial Metrics
| Metric | Q1 2009 | Q1 2008 |
|---|---|---|
| Revenue | $2,503,491 | $0 |
| Gross Profit | $185,538 | $0 |
| Operating Loss | $(1,709,285) | $(2,086,353) |
| Net Loss | $(2,528,468) | $(5,232,814) |
| Net Loss Attributable to AE Biofuels | $(2,408,763) | $(5,165,755) |
| Cash and Cash Equivalents (End of Period) | $108,827 | $555,754 |
| Total Debt (Current + Long Term) | $11,318,899 | $1,712,508 |
| Current Ratio | 0.07 | 0.15 (Dec 31, 2008) |
| Net Cash Used in Operating Activities | $(350,194) | $(966,738) |
Material Changes vs. Prior Period
- Revenue Generation: The Company recorded $2.5 million in revenue for Q1 2009, entirely from biodiesel sales in India, compared to zero revenue in Q1 2008.
- Debt Expansion: Total debt increased significantly from approximately $1.7 million in Q1 2008 to $11.3 million in Q1 2009. This includes a $5 million senior secured note issued in May 2008 and a related-party revolving line of credit.
- Interest Expense: Interest expense rose to $841,804 in Q1 2009 due to new debt facilities, compared to zero in Q1 2008.
- Non-Recurring Items: Q1 2008 included significant non-cash charges not present in Q1 2009, including a $900,000 share agreement cancellation payment and a $2.27 million registration rights payment, which contributed to the larger net loss in the prior year.
- Inventory Reduction: Inventory levels decreased from $1.05 million to $547,523, with a $65,701 write-down recorded in Q1 2009 to reflect market value below cost.
Guidance, Outlook, Risks, and Contingencies
Liquidity and Going Concern
The filing explicitly states that the Company has experienced losses and negative cash flows since inception, raising substantial doubt about its ability to continue as a going concern. As of March 31, 2009, cash reserves were sufficient to cover less than one month of domestic operating costs. The Company requires significant additional capital to fund operations, complete construction of the glycerin refinery, and meet debt obligations.
Debt Covenants and Defaults
The Company was not in compliance with financial covenants (current ratio and market capitalization) under its $5 million senior secured note with Third Eye Capital for the period of November 2008 through March 2009. Consequently, the Company accrued interest at a default rate of 18%. On May 6, 2009, the Company entered into an amendment to extend the maturity date to December 31, 2009, and waive certain defaults, subject to conditions. Failure to satisfy these conditions could result in immediate acceleration of the debt.
Legal Proceedings
A jury verdict was delivered on February 17, 2009, in favor of Cordillera Fund, L.P., regarding a dispute over Dissenters' Rights. The Company reclassified $1.75 million of Series B preferred stock as a liability ("Mandatorily redeemable Series B Preferred stock") pending the determination of fair market value by court-appointed appraisers.
Outlook
Management expects to increase biodiesel sales in 2009 but notes that margins depend on feedstock costs versus sales prices. The Company plans to complete a glycerin refinery in 2009 and is actively seeking equity and debt financing. There is no assurance that additional capital will be available.
Investor Verification Checklist
- Cash Runway: Verify current cash balances and burn rate, as the filing indicates less than one month of operating cash on hand as of March 31, 2009.
- Debt Covenant Status: Confirm the final status of the amendment with Third Eye Capital and whether the waiver conditions were fully satisfied to avoid debt acceleration.
- Legal Liability: Monitor the outcome of the appraisal process in the Cordillera Fund lawsuit to determine the final liability amount for the dissenters' rights claim.
- Capital Raising: Review subsequent filings (8-Ks) for any successful equity or debt offerings required to sustain operations.
- India Operations: Assess the operational status and profitability of the Kakinada biodiesel plant, which is the sole source of revenue, and the progress of the glycerin refinery construction.